FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W66608086> ?p ?o ?g. }

• W66608086 endingPage "68" @default.
• W66608086 startingPage "59" @default.
• W66608086 abstract "The aim of this study was to determine whether the paraoxonase (PON1) status, i.e. PON1 activities and phenotypes (AA, AB and BB), and its relationship with lipid status are different in patients with type II diabetes as compared to healthy population. Diabetic group comprised 175 patients with type II diabetes mellitus (94 men and 81 women) who came to their regular control examination and took the oral glucose tolerance test. Patients with type II diabetes mellitus diagnosis for 12 years on average were on peroral antidiabetics, or insulin or diet, and 3 patients had no therapy prescribed yet. Control group comprised 114 apparently healthy individuals (28 men and 86 women) who were not on any medication. The paraoxonase activity was measured with 2.0 mmol L(-1) paraoxon in the absence and in the presence of 1.0 mol L(-1) NaCl, and with 2.0 mmol L(-1) phenylacetate. Both activities were measured spectrophotometrically at 37 degrees C in 0.1 mol L(-1) Tris-HCl buffer, pH = 8.0, containing 2.0 mmol L(-1) CaCl(2). Sera of diabetic and control subjects were assigned to the paraoxonase phenotypes on the basis of the basal paraoxonase activity distribution. We assigned 45% sera of male and 49% sera of female diabetic patients, and 64% sera of both genders of the control group to the AA low activity phenotype. There were no differences in paraoxonase activities between the gender- and phenotype-matched diabetic and control groups. Enzyme activity against the phenylacetate was higher, and phenotype-dependent, only in diabetic patients. In contrast to AA phenotype individuals, total cholesterol and LDL-cholesterol in the female diabetic group and triglyceride concentration in the male diabetic group assigned to pooled AB and BB phenotypes were higher than in the corresponding controls. It follows from PON1 phenotype distribution that less antiatherogenic paraoxonase B allele is more frequent in type II diabetes mellitus than in the healthy population. Their lipid status is more atherogenic, which could indicate a risk of premature atherosclerosis." @default.
• W66608086 created "2016-06-24" @default.
• W66608086 creator A5007949105 @default.
• W66608086 creator A5009482973 @default.
• W66608086 creator A5017089963 @default.
• W66608086 creator A5037494439 @default.
• W66608086 creator A5041872805 @default.
• W66608086 creator A5048059073 @default.
• W66608086 creator A5049213667 @default.
• W66608086 creator A5068481296 @default.
• W66608086 creator A5068781271 @default.
• W66608086 date "2006-03-01" @default.
• W66608086 modified "2023-09-23" @default.
• W66608086 title "Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus." @default.
• W66608086 cites W1484170407 @default.
• W66608086 cites W1625479408 @default.
• W66608086 cites W1981302306 @default.
• W66608086 cites W1989245499 @default.
• W66608086 cites W2003950741 @default.
• W66608086 cites W2008232272 @default.
• W66608086 cites W2008378566 @default.
• W66608086 cites W2010064332 @default.
• W66608086 cites W2042203706 @default.
• W66608086 cites W2050601245 @default.
• W66608086 cites W2064198078 @default.
• W66608086 cites W2068939714 @default.
• W66608086 cites W2075364422 @default.
• W66608086 cites W2078159565 @default.
• W66608086 cites W2083744048 @default.
• W66608086 cites W2106402602 @default.
• W66608086 cites W2116404316 @default.
• W66608086 cites W2117131025 @default.
• W66608086 cites W2124098523 @default.
• W66608086 cites W2136995454 @default.
• W66608086 cites W2150545098 @default.
• W66608086 cites W2156092482 @default.
• W66608086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16613735" @default.
• W66608086 hasPublicationYear "2006" @default.
• W66608086 type Work @default.
• W66608086 sameAs 66608086 @default.
• W66608086 citedByCount "18" @default.
• W66608086 countsByYear W666080862012 @default.
• W66608086 countsByYear W666080862013 @default.
• W66608086 countsByYear W666080862014 @default.
• W66608086 countsByYear W666080862015 @default.
• W66608086 countsByYear W666080862017 @default.
• W66608086 countsByYear W666080862018 @default.
• W66608086 countsByYear W666080862020 @default.
• W66608086 countsByYear W666080862021 @default.
• W66608086 countsByYear W666080862022 @default.
• W66608086 crossrefType "journal-article" @default.
• W66608086 hasAuthorship W66608086A5007949105 @default.
• W66608086 hasAuthorship W66608086A5009482973 @default.
• W66608086 hasAuthorship W66608086A5017089963 @default.
• W66608086 hasAuthorship W66608086A5037494439 @default.
• W66608086 hasAuthorship W66608086A5041872805 @default.
• W66608086 hasAuthorship W66608086A5048059073 @default.
• W66608086 hasAuthorship W66608086A5049213667 @default.
• W66608086 hasAuthorship W66608086A5068481296 @default.
• W66608086 hasAuthorship W66608086A5068781271 @default.
• W66608086 hasConcept C104317684 @default.
• W66608086 hasConcept C126322002 @default.
• W66608086 hasConcept C134018914 @default.
• W66608086 hasConcept C135763542 @default.
• W66608086 hasConcept C185592680 @default.
• W66608086 hasConcept C2776151105 @default.
• W66608086 hasConcept C2776509667 @default.
• W66608086 hasConcept C2776897752 @default.
• W66608086 hasConcept C2778242859 @default.
• W66608086 hasConcept C2781389560 @default.
• W66608086 hasConcept C2908647359 @default.
• W66608086 hasConcept C2910068830 @default.
• W66608086 hasConcept C37501387 @default.
• W66608086 hasConcept C55493867 @default.
• W66608086 hasConcept C555293320 @default.
• W66608086 hasConcept C71924100 @default.
• W66608086 hasConcept C99454951 @default.
• W66608086 hasConceptScore W66608086C104317684 @default.
• W66608086 hasConceptScore W66608086C126322002 @default.
• W66608086 hasConceptScore W66608086C134018914 @default.
• W66608086 hasConceptScore W66608086C135763542 @default.
• W66608086 hasConceptScore W66608086C185592680 @default.
• W66608086 hasConceptScore W66608086C2776151105 @default.
• W66608086 hasConceptScore W66608086C2776509667 @default.
• W66608086 hasConceptScore W66608086C2776897752 @default.
• W66608086 hasConceptScore W66608086C2778242859 @default.
• W66608086 hasConceptScore W66608086C2781389560 @default.
• W66608086 hasConceptScore W66608086C2908647359 @default.
• W66608086 hasConceptScore W66608086C2910068830 @default.
• W66608086 hasConceptScore W66608086C37501387 @default.
• W66608086 hasConceptScore W66608086C55493867 @default.
• W66608086 hasConceptScore W66608086C555293320 @default.
• W66608086 hasConceptScore W66608086C71924100 @default.
• W66608086 hasConceptScore W66608086C99454951 @default.
• W66608086 hasIssue "1" @default.
• W66608086 hasLocation W666080861 @default.
• W66608086 hasOpenAccess W66608086 @default.
• W66608086 hasPrimaryLocation W666080861 @default.

• next